Evidence map›Paper›PMID 35686136›Full record

ArticleCrystals2020

Crystallization of ApoA1 and ApoE4 nanolipoprotein particles and initial XFEL-based structural studies.

M L Shelby, D Gilbile, T D Grant, W J Bauer, B Segelke, W He, A C Evans, N Crespo, P Fischer, T Pakendorf and 8 more

Open access · goldAbstract read
In one paragraph

Article in Crystals, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Preparing for successful protein crystallization experiments.Acta crystallographica. Section F, Structural biology communications · 2025
    Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. DNA-Mediated Stack Formation of Nanodiscs.Molecules (Basel, Switzerland) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 2 countries.

M L ShelbyBiosciences and Biotechnology Division, Lawrence Livermore National Laboratory, Livermore, CA, USA.
D GilbileDepartment of Chemical Engineering, University of California at Davis, Davis, CA, USA.
T D GrantDepartment of Structural Biology, Jacobs School of Medicine and Biomedical Sciences, SUNY University at Buffalo, Buffalo, NY, USA.
W J BauerHauptman-Woodward Medical Research Institute, Buffalo, NY, USA.
B SegelkeBiosciences and Biotechnology Division, Lawrence Livermore National Laboratory, Livermore, CA, USA.
W HeBiosciences and Biotechnology Division, Lawrence Livermore National Laboratory, Livermore, CA, USA.
A C EvansBiosciences and Biotechnology Division, Lawrence Livermore National Laboratory, Livermore, CA, USA.
N CrespoDepartment of Structural Biology, Jacobs School of Medicine and Biomedical Sciences, SUNY University at Buffalo, Buffalo, NY, USA.
P FischerCenter for Free-Electron Laser Science, Hamburg, Germany.
T PakendorfCenter for Free-Electron Laser Science, Hamburg, Germany.
V HennickeCenter for Free-Electron Laser Science, Hamburg, Germany.
M S HunterLinac Coherent Light Source, SLAC National Accelerator Laboratory, Menlo Park, California, USA.
A BatyukLinac Coherent Light Source, SLAC National Accelerator Laboratory, Menlo Park, California, USA.
M BarthelmessCenter for Free-Electron Laser Science, Hamburg, Germany.
A MeentsCenter for Free-Electron Laser Science, Hamburg, Germany.
T L KuhlDepartment of Chemical Engineering, University of California at Davis, Davis, CA, USA.
M FrankBiosciences and Biotechnology Division, Lawrence Livermore National Laboratory, Livermore, CA, USA.
M A ColemanBiosciences and Biotechnology Division, Lawrence Livermore National Laboratory, Livermore, CA, USA.
Lawrence Livermore National Laboratory · USUniversität Hamburg · DEHauptman-Woodward Medical Research Institute · USSLAC National Accelerator Laboratory · USUniversity of California, Davis · US

Funding

Project 1. Nanolipoprotein-supported multi-subunit vaccine for Chlamydia trachomatisU19AI144184 · NIAID · UNIVERSITY OF CALIF-LAWRNC LVRMR NAT LAB · PI COLEMAN, MATTHEW ADRIAN · 2019 to 2023
$10.0M
Technology development for biological imaging with x-ray free electron lasersR01GM117342 · NIGMS · LAWRENCE LIVERMORE NATIONAL SECURITY, LLC · PI FRANK, MATTHIAS · 2016 to 2024
$4.8M
NIAID NIH HHS U19 AI144184NIGMS NIH HHS R01 GM117342
6 · The paper itself

Abstract

Nanolipoprotein particles (NLPs), also called "nanodiscs", are discoidal particles with a patch of lipid bilayer corralled by apolipoproteins. NLPs have long been of interest due to both their utility as membrane-model systems into which membrane proteins can be inserted and solubilized and their physiological role in lipid and cholesterol transport via HDL and LDL maturation, which are important for human health. Serial femtosecond crystallography (SFX) at X-ray free electron lasers (XFELs) is a powerful approach for structural biology of membrane proteins, which are traditionally difficult to crystallize as large single crystals capable of producing high-quality diffraction suitable for structure determination. To facilitate understanding of the specific role of two apolipoprotein/lipid complexes, ApoA1 and ApoE4, in lipid binding and HDL/LDL particle maturation dynamics and develop new SFX methods involving NLP membrane protein encapsulation, we have prepared and crystallized homogeneous populations of ApoA1 and ApoE4 NLPs. Crystallization of empty NLPs yields semi-ordered objects that appear crystalline and give highly anisotropic and diffuse X-ray diffraction, similar in characteristics to fiber diffraction. Several unit cell parameters were approximately determined for both NLPs from these measurements. Thus, low-background, sample conservative methods of delivery are critical. Here we implemented a fixed target sample delivery scheme utilizing the Roadrunner fast-scanning system and ultra-thin polymer/graphene support films, providing a low-volume, low-background approach to membrane protein SFX. This study represents initial steps in obtaining structural information for ApoA1 and ApoE4 NLPs and developing this system as a supporting scaffold for future structural studies of membrane proteins crystalized in a native lipid environment.

Indexed as

fixed target deliverylipoproteinnanodiscserial femtosecond crystallographyXFELs

Identifiers

PMID35686136
PMCPMC9175823
OpenAlexW3089832657

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.